You searched for Humanized antibody - Page 37 of 44

News and Trends 3 May 2023

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline

…decline, respectively. The incidence of amyloid-related imaging abnormalities (ARIA) was consistent with the TRAILBLAZER-ALZ phase 2 study. ARIA is observed with the amyloid plaque clearing antibody class of therapies and…

May 3, 2023 - 8 minutesmins - By Jim Cornall

In Depth 17 Jan 2025

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

…antibody targeting PD-L1 and VEGF-A had a 69.7% overall survival rate at 18 months. While the drug overtook Keytruda in the clinic, the question remains of whether the candidate will…

January 17, 2025 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 7 Mar 2024

6 biotech companies tackling antibiotic resistance

…– expected in the first quarter of 2025. Clarametyx Biosciences Launched in 2020 to advance a novel, immune-enabling antibody technology licensed from Nationwide Children’s Hospital, Clarametyx Biosciences is combating persistent…

March 7, 2024 - 8 minutesmins - By Willow Shah-Neville

Startup Scout 21 Feb 2020

This Startup is Developing Anti-Aging Antibodies

The Heidelberg-based startup Velabs Therapeutics aims to make anti-aging drugs that selectively destroy ‘aged’ cells in the body. Mission: To develop antibody drugs using microfluidics technology that can kill old…

February 21, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 27 Nov 2018

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Adrenomed closed a €24M Series D round to fund further development of its antibody drug that treats septic shock by preventing excessive fluid loss and preserving the blood vessel walls….

November 27, 2018 - 3 minutesmins - By Helen Albert

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

…Gilead Sciences’ remdesivir. In November and December, several antibody drugs were greenlit, including regdanvimab developed by the South Korean company Celltrion and sotrovimab, marketed by GSK. However, the rise of…

February 15, 2022 - 7 minutesmins - By Jonathan Smith

In Depth 5 Nov 2024

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

…as ANB033 (anti-CD122 antagonist antibody) entering a phase 1 trial, and ANB101 (BDCA2 modulator antibody) in preclinical development. Moreover, just after it announced it wanted to separate its consumer health…

November 5, 2024 - 9 minutesmins - By Jules Adam

mereo biopharma brittle bone disease osteogenesis imperfecta

More News! 11 Nov 2019

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

…bone disease. Mereo tested different doses of its antibody drug in 112 adults with osteogenesis imperfecta in a 12-month phase IIb trial. The drug failed to meet the main endpoint…

November 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2023

Disc Medicine raises $62.5M for hematology programs

…DISC-0974 (hepcidin suppression) is another treatment in the pipeline. It is a first-in-class, investigational, anti-hemojuvelin (HJV) monoclonal antibody designed to suppress hepcidin production and increase serum iron to enable erythropoiesis….

February 14, 2023 - 2 minutesmins - By Jim Cornall

Best in Biotech 2 Apr 2024

Chicago biotech: Seven players advancing the industry

…is a biopharmaceutical company focused on developing therapies that target senescent cells and cancer. Their leading compound, SIWA318H, is an antibody that targets advanced glycation end products (AGEs), which are…

April 2, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…Among them is a vaccine for malaria, which has received significant attention and funding, including $12.2 million from the EU Malaria Fund. Another prominent candidate is MAbCo19, a monoclonal antibody…

August 22, 2024 - 9 minutesmins - By Jules Adam

News and Trends 13 Dec 2017

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Regeneron and Sanofi have announced positive early results from a Phase II study investigating their skin cancer antibody, cemiplimab. Despite deciding to end their antibody partnership at the end of…

December 13, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline

Are PD-1 and PD-L1 checkpoint inhibitors as good as we thought?

6 biotech companies tackling antibiotic resistance

This Startup is Developing Anti-Aging Antibodies

Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

From consumer health to pure biopharma: Inside Sanofi’s strategic shift

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

Disc Medicine raises $62.5M for hematology programs

Chicago biotech: Seven players advancing the industry

Seven companies transforming the biotech industry in Italy

Biotech and Pharma Giants Make a Good Start to Phase II Trial for Skin Cancer

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!